World Tuberculosis Day - 2018
World Tuberculosis Day - marked each year on 24 March – is an occasion to raise awareness and advocate for efforts to eliminate TB.
Public consultation on strengthening cooperation against vaccine-preventable diseases
Have your say on EC consultation on how to increase vaccination coverage in the EU
WHO recommendations for influenza virus vaccine composition for the 2018-2019 Northern hemisphere season
On 19-21 February 2018 the World Health Organization (WHO) agreed on the recommended composition of the trivalent influenza vaccine for the northern hemisphere 2018-2019 influenza season; A/Michigan/45/2015 (H1N1)pdm09-like virus, A/Singapore/INFIMH-16-0019/2016 (H3N2)-like virus, B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage). The WHO recommendations are made with a knowledge of the currently circulating viruses globally. WHO recommended two changes, compared to the current trivalent and quadrivalent vaccines for the 2017–2018 season in the northern hemisphere influenza season.
Low uptake of seasonal influenza vaccination in Europe may jeopardise capacity to protect people in next pandemic
Influenza vaccination coverage among high-risk groups has dropped in the European Region over the last seven years, and half the countries report a decrease in the number of vaccine doses available.
Yellow fever transmission could affect urban areas in Brazil, increasing the risk to travellers, especially during Carnival
ECDC issues new risk assessment in light of the yellow fever resurgence in Brazil (in particular in São Paulo) and the expected increasing flow of travellers during the upcoming Carnival.
Measles in the EU/EEA: current outbreaks, latest data and trends – January 2018
Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations. Since the beginning of 2016, 49 deaths due to measles have been reported in the EU,
Measles in the EU/EEA: current outbreaks, latest data and trends – December 2017
Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations. Since the beginning of 2016, 48 deaths due to measles were reported in the EU.
Expert opinion on meningococcal B vaccine – information and suggestions to EU/EEA countries
The ECDC expert opinion provides information on the burden of serogroup B invasive meningococcal disease in the EU/EEA, includes general considerations for 4CMenB introduction such as vaccine immunogenicity, safety, cost-effectiveness, ease of implementation and areas for country collaboration, and highlights different options for vaccine introduction.